Axim Biotechnologies Stock Buy Hold or Sell Recommendation
| AXIM Stock | USD 0 0 50.00% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Axim Biotechnologies is 'Strong Sell'. The recommendation algorithm takes into account all of Axim Biotechnologies' available fundamental, technical, and predictive indicators you will find on this site.
Check out Axim Biotechnologies Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Axim and provide practical buy, sell, or hold advice based on investors' constraints. Axim Biotechnologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
Axim |
Execute Axim Biotechnologies Buy or Sell Advice
The Axim recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Axim Biotechnologies. Macroaxis does not own or have any residual interests in Axim Biotechnologies or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Axim Biotechnologies' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Weak | Details | |
Volatility | Out of control | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Very regressive towards the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Axim Biotechnologies Trading Alerts and Improvement Suggestions
| Axim Biotechnologies had very high historical volatility over the last 90 days | |
| Axim Biotechnologies has some characteristics of a very speculative penny stock | |
| Axim Biotechnologies has a very high chance of going through financial distress in the upcoming years | |
| Axim Biotechnologies currently holds 5.06 M in liabilities with Debt to Equity (D/E) ratio of 1.36, which is about average as compared to similar companies. Axim Biotechnologies has a current ratio of 0.06, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Axim Biotechnologies until it has trouble settling it off, either with new capital or with free cash flow. So, Axim Biotechnologies' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Axim Biotechnologies sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Axim to invest in growth at high rates of return. When we think about Axim Biotechnologies' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 60.46 K. Net Loss for the year was (16.03 M) with profit before overhead, payroll, taxes, and interest of 60.46 K. | |
| Axim Biotechnologies currently holds about 65.16 K in cash with (2.49 M) of positive cash flow from operations. | |
| Roughly 41.0% of Axim Biotechnologies shares are held by company insiders |
Axim Biotechnologies Returns Distribution Density
The distribution of Axim Biotechnologies' historical returns is an attempt to chart the uncertainty of Axim Biotechnologies' future price movements. The chart of the probability distribution of Axim Biotechnologies daily returns describes the distribution of returns around its average expected value. We use Axim Biotechnologies price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Axim Biotechnologies returns is essential to provide solid investment advice for Axim Biotechnologies.
| Mean Return | -0.03 | Value At Risk | -25 | Potential Upside | 33.33 | Standard Deviation | 19.61 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Axim Biotechnologies historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Axim Biotechnologies Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Axim Biotechnologies or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Axim Biotechnologies' price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Axim pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.05 | |
β | Beta against Dow Jones | -0.74 | |
σ | Overall volatility | 19.96 | |
Ir | Information ratio | -0.0079 |
Axim Biotechnologies Volatility Alert
Axim Biotechnologies is displaying above-average volatility over the selected time horizon. Axim Biotechnologies is a penny stock. Even though Axim Biotechnologies may be a good instrument to invest, many penny pink sheets are speculative instruments that are subject to artificial stock promotions. Please make sure you fully understand upside and downside scenarios of investing in Axim Biotechnologies or similar risky assets. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings,sudden promotions and many other similar artificial hype indicators. We also encourage traders to check work history of company executives before investing in high-volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Axim instrument if you perfectly time your entry and exit. However, remember that penny pink sheets that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Axim Biotechnologies Fundamentals Vs Peers
Comparing Axim Biotechnologies' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Axim Biotechnologies' direct or indirect competition across all of the common fundamentals between Axim Biotechnologies and the related equities. This way, we can detect undervalued stocks with similar characteristics as Axim Biotechnologies or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of Axim Biotechnologies' fundamental indicators could also be used in its relative valuation, which is a method of valuing Axim Biotechnologies by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Axim Biotechnologies to competition |
| Fundamentals | Axim Biotechnologies | Peer Average |
| Return On Equity | -100.19 | -0.31 |
| Return On Asset | -0.35 | -0.14 |
| Operating Margin | (847.86) % | (5.51) % |
| Current Valuation | 13.6 M | 16.62 B |
| Shares Outstanding | 186.44 M | 571.82 M |
| Shares Owned By Insiders | 40.97 % | 10.09 % |
| Price To Earning | (53.71) X | 28.72 X |
| Price To Book | 2.86 X | 9.51 X |
| Price To Sales | 943.93 X | 11.42 X |
| Revenue | 60.46 K | 9.43 B |
| Gross Profit | 60.46 K | 27.38 B |
| EBITDA | (13.42 M) | 3.9 B |
| Net Income | (16.03 M) | 570.98 M |
| Cash And Equivalents | 65.16 K | 2.7 B |
| Total Debt | 5.06 M | 5.32 B |
| Debt To Equity | 1.36 % | 48.70 % |
| Current Ratio | 0.06 X | 2.16 X |
| Book Value Per Share | (0.02) X | 1.93 K |
| Cash Flow From Operations | (2.49 M) | 971.22 M |
| Earnings Per Share | (0.13) X | 3.12 X |
| Number Of Employees | 6 | 18.84 K |
| Beta | 1.49 | -0.15 |
| Market Capitalization | 4.64 M | 19.03 B |
| Total Asset | 5.32 M | 29.47 B |
| Retained Earnings | (36.37 M) | 9.33 B |
| Working Capital | (1.36 M) | 1.48 B |
| Current Asset | 1.18 M | 9.34 B |
| Current Liabilities | 2.55 M | 7.9 B |
| Z Score | -15.0 | 8.72 |
| Net Asset | 5.32 M |
Axim Biotechnologies Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Axim . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Axim Biotechnologies Buy or Sell Advice
When is the right time to buy or sell Axim Biotechnologies? Buying financial instruments such as Axim Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Axim Biotechnologies in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Corona Opportunity Thematic Idea Now
Corona Opportunity
Firms that are involved in some capacity in making products or providing services to the public to buttle the virus directly or indirectly. This also includes some defencive and contrarian stocks and ETFs that are managing to avoid the big market correction coused by coronavirus. The Corona Opportunity theme has 46 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Corona Opportunity Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Axim Pink Sheet
Axim Biotechnologies financial ratios help investors to determine whether Axim Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Axim with respect to the benefits of owning Axim Biotechnologies security.